Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Hansoh Pharmaceutical Group Company Limited (3692) Stock Price & Analysis

8 Followers

3692 Stock Chart & Stats

HK$34.36-HK$0.66(-1.88%)
At close: 4:00 PM GMT+8
HK$32HK$34HK$36Aug 17Aug 31Sep 14Sep 28Oct 12Oct 26Nov 9
Day’s Range
HKD 34.04 - HKD 34.90
52-Week Range
HKD 28.06 - HKD 44.22
Previous Close
HKD 35.02
Volume
N/A
Average Volume (3M)
10.16M
Market Cap
HKD 212.37B
Enterprise Value
HKD 143.50B
Total Cash (Recent Filing)
HKD 37.38B
Total Debt (Recent Filing)
HKD 4.23B
Price to Earnings (P/E)
27.2
Beta
0.60
Next Earnings
Mar 30, 2027 (Est.)
EPS Estimate
0.57
Last Dividend Ex-Date
Sep 22, 2026
Dividend Yield
1.41%

Bulls Say, Bears Say

Bulls Say

Re-accelerating Revenue Growth

Revenue growth re-accelerated to 11% in 2025 after a flat 2024, indicating renewed commercial momentum across the portfolio. If sustained, improving top-line expansion can support investment in product launches, lifecycle management, and broader commercialization over the next several quarters.

Exceptional Profitability

Exceptionally high gross and net margins provide substantial earnings resilience and internal funding capacity. Consistent profitability gives Hansoh room to finance research, development, regulatory work, and market access while retaining more cash from each additional unit of revenue.

Strong Balance Sheet And Cash Generation

Very low leverage reduces financial strain, while 2025 operating cash flow exceeded net income and free cash flow closely tracked earnings. This combination supports durable funding for innovation and commercialization without heavy reliance on borrowing or external capital.

Bears Say

Volatile Cash Conversion

The sharp variation in operating cash flow conversion shows that reported earnings do not translate into cash consistently every year. Such volatility can complicate budgeting and reduce confidence in internally generated funding, even though 2025 cash generation was strong.

Margin Variability

Margin performance has not been uniform across years, with operating margin declining in 2024 despite otherwise strong profitability. Continued variability could limit earnings predictability and weaken the durability of returns if cost or product-mix pressures persist.

Mainland China Concentration

Hansoh’s primary exposure to mainland China concentrates commercial performance in one national market and its hospital and retail channels. This limits geographic diversification and makes sustained results more dependent on conditions affecting that market and distribution system.

Hansoh Pharmaceutical Group Company Limited News

3692 FAQ

What was Hansoh Pharmaceutical Group Company Limited’s price range in the past 12 months?
Hansoh Pharmaceutical Group Company Limited lowest stock price was HK$28.06 and its highest was HK$44.22 in the past 12 months.
What is Hansoh Pharmaceutical Group Company Limited’s market cap?
Hansoh Pharmaceutical Group Company Limited’s market cap is HK$212.37B.
When is Hansoh Pharmaceutical Group Company Limited’s upcoming earnings report date?
Hansoh Pharmaceutical Group Company Limited’s next earnings report is estimated for Mar 30, 2027 (not yet confirmed), which is in 138 days.
How were Hansoh Pharmaceutical Group Company Limited’s earnings last quarter?
Hansoh Pharmaceutical Group Company Limited released its earnings results on Aug 26, 2026. The company reported HK$0.818 earnings per share for the quarter, beating the consensus estimate of HK$0.573 by HK$0.245.
Is Hansoh Pharmaceutical Group Company Limited overvalued?
According to Wall Street analysts Hansoh Pharmaceutical Group Company Limited’s price is currently Undervalued.
Does Hansoh Pharmaceutical Group Company Limited pay dividends?
Hansoh Pharmaceutical Group Company Limited pays a semiannual dividend of HK$0.285 which represents an annual dividend yield of 1.41%. See more information on Hansoh Pharmaceutical Group Company Limited dividends here
What is Hansoh Pharmaceutical Group Company Limited’s EPS estimate?
Hansoh Pharmaceutical Group Company Limited’s EPS estimate is 0.57.
How many shares outstanding does Hansoh Pharmaceutical Group Company Limited have?
Hansoh Pharmaceutical Group Company Limited has 6,064,150,000 shares outstanding.
What happened to Hansoh Pharmaceutical Group Company Limited’s price movement after its last earnings report?
Hansoh Pharmaceutical Group Company Limited reported an EPS of HK$0.818 in its last earnings report, beating expectations of HK$0.573. Following the earnings report the stock price went up 0.508%.
Which hedge fund is a major shareholder of Hansoh Pharmaceutical Group Company Limited?
Currently, no hedge funds are holding shares in HK:3692
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology